Gnbt..تقرير رفعها ...

[ELASBANI]

السلام عليكم
عليها اليوم الكلام التالي :
TORONTO, Sep 27, 2006 (MARKET WIRE via COMTEX) -- Generex Biotechnology Corporation ( GNBT ) announced today that Torc Investments and Research LLC, a NASD registered broker-dealer, initiated research coverage of the Company today with a Buy rating and a 12-month price target of $3-$3.50.

The Report, issued by Director of Research Amanda McNamara, noted that, "The company's main product is centered on diabetes, a very lucrative and growing market where it is estimated that 350 million people worldwide will be affected by 2025 (up from 230 million currently)

وهذا رفعها اليوم 15% ..
اخر سعر 1.87

مالم ترجع فوق ال 2 دولار ..
يمكن العودة لشراء السهم 1.40
والله أعلم ..

[ELASBANI]

وضعنا لهم امر الشراء المفتوح على 1.41
والرزق على الله ..

[gulf29]

Salam 3lekm
how r u my my friend

gnbt must be above 2 $ this month

good luck

[ELASBANI]

Salam 3lekm
how r u my my friend

gnbt must be above 2 $ this month

good luck

أهلا أهلا بالناس الطيبة
مبروك شهرك
نحن بخير والحمد لله ..

السهم يحتاج هذا الوقت الطويل للتعرف عليه ومستثمر مضارب به
والامور جيدة والحمد لله..
نعم الدخول به لو تحسن بالرجوع فوق ال 2 والا تعب

تماما مثل GNTA ومالم ترجع فوق 1 /1.2 سيتعب من يدخل
... ماعدا الحركات السريعة ..للمضاربة..

تحية لك وللجميع ونذكر ستريمر ويوسف واسامة والكثير .....

[ELASBANI]

Salam 3lekm
how r u my my friend

gnbt must be above 2 $ this month

good luck

NOW
Last 2.04
:) :)

[gulf29]

Thanks allah

and good luck

[ELASBANI]

وهل سيعمل السهم العروة وينطلق بعدها؟؟
اريد المضاربة في غوغل يا جينيركس......

[pastate]

اما ازلت تفكر بالعروة يالاسباني ؟!!

:)

[ELASBANI]

نعم أخي العزيز
والسهم يتحرك فنيا بصورة جيدة.. وان شاي الله بكملها ...
هاي اليوم 2.25 مقاومة واضحة ..على سبيل المثال ..

[المعمر]

حتى هم عندهم كويب وعروه مثلنا :)

بالتوفيق ان شاء الله

افكر وبجديه تغير نشاطي من السوق السعودي .. من غير رجعه

[ELASBANI]

اخبار جيدة للمضاربة اليوم
Company Signs Agreement With the Lebanese-Canadian Hospital in Beirut as a Site for Trials

TORONTO, Nov 06, 2006 (MARKET WIRE via COMTEX) -- Generex Biotechnology Corporation ( GNBT ) announced today that it has entered into an agreement with the Lebanese-Canadian Hospital in Beirut, Lebanon to conduct a human clinical trial of the Antigen Express synthetic avian influenza vaccine, representing the first studies to be conducted in man. The study is being undertaken with the approval of the appropriate Lebanese governmental and regulatory bodies. Antigen Express, Inc., a wholly owned subsidiary of Generex, designed the vaccine using its proprietary platform technology and has been conducting pre-clinical studies since 2004. Dr. Alexander Abdelnoor, Department of Microbiology & Immunology, Faculty of Medicine, American University of Beirut, will also be participating as a consultant for the trials.

[pastate]

شكرا على التذكير

و لا تنسى Nt اليوم عليها حركة

[ELASBANI]

واخبار
لرفع السهم ولازم يقفل فوق ال 2.32 لنتأكد استمرار الارتفاع....
على العموم انا وضعت امر بيع جزئي ومن امس حيث بدأ الارتفاع ....... لربما صديقنا الد. سهم يعرف اين
........
First Metformin Gum Patent Granted to Generex Biotechnology
11/14/2006 9:45:42 AM
TORONTO, Nov 14, 2006 (MARKET WIRE via COMTEX) -- Generex Biotechnology Corporation ( GNBT ), the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that it has been granted the first patent for its medicinal gum platform titled "Compositions for Oral Transmucosal Delivery of Metformin." The patent covers claims to the composition, processes, and methodologies for the delivery of an oral transmucosal metformin composition via the oral mucosal membrane for absorption.

This patent was issued by the Lebanese Ministry of National Economy Intellectual Property Protection Office. As a consequence of Lebanon's accession to the international Patent Co-operation Treaty, this patent will open the door to further filings in the other PCT signatory countries.

Metformin is a generic drug used to regulate blood glucose (sugar) levels by reducing the amount of glucose produced by the liver, and by making the insulin produced by the body work more effectively to reduce the amount of glucose already in the blood. Metformin has been in use around the world for more than 30 years. It remains the most prescribed drug for Type-2 diabetes, a testimony to its efficacy and its prominent place in diabetes therapy. The total US market sales of all forms of metformin are approximately $1.8 Billion (IMS-MAT: December 2003).

The patent relates to an oral transmucosal metformin composition comprising a pharmaceutically acceptable carrier being capable of delivering a pharmaceutically effective amount of metformin to the oral mucosal membrane for absorption.

[ELASBANI]

السلام عليكم

تحرك قوي على السهم اليوم
عمل الهاي 2.02
((بيحبوا الارقام العجيبة هم أيضا))...لنضعها في الاعتبار ...

نراقب الى اين البول باك ...
1.90 ربما ؟؟؟
اللو 1.84 للعلم والآن 1.95

تحية للجميع

[ELASBANI]

السلام عليكم
الاخبار الجيدة بخصوص احد منتجاتها رفعها امس واليوم ..
من حول ال 1.30 والى آخر سعر الان 2.12
ماشاء الله يالاسهم الطبية ..اما ملل او جنون..
نتابع بقاءه فوق ال 2 اليوم ام لا
مبروك لمن يملك .....وحظ سئ لأصحاب الحظ السئ..